Do *not* scratch it.

Icotyde is the first targeted oral peptide IL‑23 receptor antagonist, designed to interrupt a core psoriasis inflammatory axis while avoiding injection-based administration typical of IL‑23 biologics.

A sweaty scalp in summer can cause itching, dandruff and greasy hair. Here are the causes of a sweaty scalp and some simple tips to keep your hair fresh and healthy during hot weather.

Dermatologists explain the common symptoms of an unhealthy scalp, as well as how to treat it.

AA-IGA and Scalp Hair Assessment PRO stratify severity into five categories, with the PRO enabling patient-centered monitoring and treatment personalization. AASc and ASAMI incorporate extra-scalp ...

Hair loss, dryness, split ends and dandruff have become common problems. People use expensive shampoos and treatments to get ...

NEW YORK, NY, UNITED STATES, March 16, 2026 /EINPresswire.com/ -- Aglow Dermatology announces the launch of its Hair ...

FDA approval covers adults and adolescents ≥12 years (≥88 lbs) with moderate-to-severe plaque psoriasis requiring systemic therapy or phototherapy, expanding systemic options beyond injectables.

Over the past decade, dermatologists and wellness specialists have noticed a significant uptick in women seeking treatment ...

ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety profile in a once-daily pill Approval supported by four phase 3 studies that met ...

UniQure does not have to drill placebo burr holes in the skulls of patients with Huntington's disease, an unnamed FDA senior official said on Thursday. Instead, the company would anesthetize them and ...

The FDA approved icotrokinra for adults and adolescents aged 12 years and older with moderate to severe plaque psoriasis, Johnson & Johnson announced in a press release. Icotrokinra (Icotyde) is the ...